{"id":"W2166003630","doi":"10.1634/theoncologist.11-6-624","title":"End Points for Adjuvant Therapy Trials: Has the Time Come to Accept Disease-Free Survival as a Surrogate End Point for Overall Survival?","year":2006,"lang":"en","type":"article","venue":"The Oncologist","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Surrogate endpoint; Clinical endpoint; Clinical trial; Adjuvant therapy; Adjuvant; End point; Endpoint Determination; Intensive care medicine; Disease; Oncology; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4186936,0.001703098,0.008130233,0.002492441,0.001347107,0.009856276,0.003624429,0.008260157,0.003800257],"category_scores_gemma":[0.4555847,0.0007633432,0.004017596,0.00620754,0.005845733,0.01028096,0.003670929,0.01590042,0.001960691],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003440709,"about_ca_system_score_gemma":0.00840166,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006209988,"about_ca_topic_score_gemma":0.0009117984,"domain_scores_codex":[0.6353787,0.3218865,0.01997295,0.003374614,0.01867456,0.0007126392],"domain_scores_gemma":[0.5021564,0.4245039,0.03143837,0.01825651,0.01984026,0.003804574],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.01803801,0.000337977,0.01189175,0.02320468,0.002808368,0.0004025908,0.001453488,0.003459973,0.001434481,0.1721497,0.030347,0.734472],"study_design_scores_gemma":[0.01669401,0.01295662,0.01397629,0.05373508,0.003063067,0.001706651,0.001383385,0.01420895,0.002010716,0.5607546,0.3188339,0.0006768091],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"review","genre_gemma":"commentary","genre_scores_codex":[0.01273052,0.4560532,0.1857505,0.300718,0.02345314,0.004594067,0.001314459,0.000268049,0.01511797],"genre_scores_gemma":[0.1881969,0.1978786,0.3730263,0.1713822,0.02735389,0.03361456,0.002176238,0.0006718479,0.005699501],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.5813065,"threshold_uncertainty_score":0.7168543,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1089362530739013,"score_gpt":0.3720933818658209,"score_spread":0.2631571287919195,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}